trastuzumab deruxtecan for her2-mutated metastatic nsclc
Published 2 years ago • 238 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
1:10
dr. bunn on data with trastuzumab deruxtecan in her2-mutant nsclc
-
6:18
treating her2 exon-20 insertion nsclc with trastuzumab deruxtecan - case based panel discussion
-
5:40
trastuzumab deruxtecan doubles pfs in metastatic breast cancer with low her2 expression
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
1:38
dr. peters discusses ongoing research with trastuzumab deruxtecan in nsclc
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
7:30
neratinib plus fulvestrant for her2 mutant, non-amplified metastatic breast cancer
-
21:00
gs4 10 neratinib fulvestrant trastuzumab for hormone receptor-positive, her2-mutant metastatic
-
5:45
#esmo21 expert video report on targeting in her2-positive metastatic breast and lung cancers
-
6:07
updated results from a trial of trastuzumab deruxtecan for her2-positive breast cancer
-
1:12
trastuzumab deruxtecan in metastatic her2 breast cancer
-
5:26
trastuzumab deruxtecan shows benefit in patients with her2 mbc
-
5:25
asco: promising results for trastuzumab deruxtecan for her2 gastric cancer
-
17:15
her2 targeted therapy for treatment of nsclc
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
2:07
subtypes of egfr- and her2-mutant metastatic nsclc influence response to icis
-
6:45
trastuzumab deruxtecan for patients w/ her2-positive advanced gastric or ge junction adenocarcinoma